Tag: diagnostic

Failure to detect mutations in U2AF1 due to changes in the GRCh38 reference sequence

Materials and Methods Genomic data was collected as part of the MDS National History Study or The Cancer Genome Atlas project and consented appropriately under those protocols 8 Sekeres M.A. Gore S.D. Stablein D.M. DiFronzo N. Abel G.A. DeZern A.E. Troy J.D. Rollison D.E. Thomas J.W. Waclawiw M.A. Liu J.J….

Continue Reading Failure to detect mutations in U2AF1 due to changes in the GRCh38 reference sequence

A one-pot CRISPR/Cas13a-based contamination-free biosensor for low-cost and rapid nucleic acid diagnostics

Available online 13 January 2022, 113994 doi.org/10.1016/j.bios.2022.113994Get rights and content Highlights • A one-pot CRISPR/Cas13a-based visual biosensor for the rapid and low-cost nucleic acid detection is proposed. • With a newly developed tube-in-tube vessel used in the biosensor, aerosol cross contamination could be completely avoided. • The sensor can not…

Continue Reading A one-pot CRISPR/Cas13a-based contamination-free biosensor for low-cost and rapid nucleic acid diagnostics

Long non-coding RNA MSTRG.81401 short hairpin RNA relieves diabetic neuropathic pain and behaviors of depression by inhibiting P2X4 receptor expression in type 2 diabetic rats

1. Nicodemus JM, Enriquez C, Marquez A, Anaya CJ, Jolivalt CG (2017) Murine model and mechanisms of treatment-induced painful diabetic neuropathy. Neuroscience 354:136–145. doi.org/10.1016/j.neuroscience.2017.04.036 CAS  Article  PubMed  Google Scholar  2. Morimoto SS, Kanellopoulos D, Manning KJ, Alexopoulos GS (2015) Diagnosis and treatment of depression and cognitive impairment in late life….

Continue Reading Long non-coding RNA MSTRG.81401 short hairpin RNA relieves diabetic neuropathic pain and behaviors of depression by inhibiting P2X4 receptor expression in type 2 diabetic rats

UniProtKB/SwissProt variant VAR_085098

Sequence information Variant position:  322 The position of the amino-acid change on the UniProtKB canonical protein sequence. Protein sequence length:  360 The length of the canonical sequence. Location on the sequence:   IEVEQALAHPYLEQYYDPSD  E PIAEAPFKFDMELDDLPKEK The residue change on the sequence. Unless the variant is located at the beginning or at the end of…

Continue Reading UniProtKB/SwissProt variant VAR_085098

Prometheus Biosciences Provides Corporate Updates at the 40th Annual J.P. Morgan Healthcare … | News

– Fast Track Designation granted from U.S. Food and Drug Administration for PRA023 for the treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) – – New patent granted for PRA023 companion diagnostic (CDx) reinforces Prometheus’ precision approach and extends CDx patent coverage into 2040 – – Company to present today…

Continue Reading Prometheus Biosciences Provides Corporate Updates at the 40th Annual J.P. Morgan Healthcare … | News

Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures

Summary Background Inter-individual variability during sepsis limits appropriate triage of patients. Identifying, at first clinical presentation, gene expression signatures that predict subsequent severity will allow clinicians to identify the most at-risk groups of patients and enable appropriate antibiotic use. Methods Blood RNA-Seq and clinical data were collected from 348 patients…

Continue Reading Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures

Correlation Analysis of circRNA Circ_0071662 in Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma

This article was originally published here Int J Gen Med. 2021 Dec 29;14:10423-10428. doi: 10.2147/IJGM.S343889. eCollection 2021. ABSTRACT BACKGROUND: The role of circRNA circ_0071662 has been studied in bladder cancer. The present study aimed to analyze its involvement in esophageal squamous cell carcinoma (ESCC). METHODS: Patients with ESCC (n =…

Continue Reading Correlation Analysis of circRNA Circ_0071662 in Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma

Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review

Background: Autoantibody specificity in autoimmune diseases is variable due to each patient’s individual spectrum of autoantibodies and the inherent differences between detection methods and tests. Since false-positive results have downstream consequences, we conducted a comprehensive assessment of anti-double stranded DNA (anti-dsDNA) specificity from published studies of systemic lupus erythematosus (SLE)….

Continue Reading Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review

Rapid and sensitive point-of-care detection of Leptospira by RPA-CRISPR/Cas12a targeting lipL32.,PLOS Neglected Tropical Diseases

Rapid and sensitive point-of-care detection of Leptospira by RPA-CRISPR/Cas12a targeting lipL32. PLOS Neglected Tropical Diseases ( IF 4.411 ) Pub Date : 2022-01-06 , DOI: 10.1371/journal.pntd.0010112 Sirawit Jirawannaporn,Umaporn…

Continue Reading Rapid and sensitive point-of-care detection of Leptospira by RPA-CRISPR/Cas12a targeting lipL32.,PLOS Neglected Tropical Diseases

Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe

Added whole genome sequencing capacity enables the SOLVE-RD research program to significantly increase sample throughput MENLO PARK, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical Center (Radboudumc) in Nijmegen, the Netherlands will increase their…

Continue Reading Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe

Identification of missed viruses by metagenomic sequencing of clinical respiratory samples from Kenya

The detection of viruses As shown in Table 1, viral NGS identified at least one syndrome-associated mammalian virus in 35 of 95 Kilifi County Hospital (KCH) inpatient samples (36.8%) and 23 of 95 household cohort (study investigating Who-Acquires-Infection-From-Whom, WAIFW) samples (24.2%), leading to an overall 30.5% “missed virus detection rate”….

Continue Reading Identification of missed viruses by metagenomic sequencing of clinical respiratory samples from Kenya

Comparison of CNV analysis methods: Array CGH vs NGS

Rare genetic disorders are caused by variants in major functional genes. Most are SNV or INDEL variants, but SVs, such as CNVs or chromosomal variants, can also be the cause. Recently, a large-scale study has also been published showing that CNVs were identified in 11-12% more infants and children with…

Continue Reading Comparison of CNV analysis methods: Array CGH vs NGS

NIH Study Shows Using CareDx’s AlloSure Lung for Transplant Surveillance is More Effective than Diagnostic Bronchoscopy at Identifying Rejection

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) — CareDx, Inc.,  (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the results of a study led by the National Institutes of…

Continue Reading NIH Study Shows Using CareDx’s AlloSure Lung for Transplant Surveillance is More Effective than Diagnostic Bronchoscopy at Identifying Rejection

Genetic diagnosis of basal ganglia disease in childhood

This article was originally published here Dev Med Child Neurol. 2022 Jan 5. doi: 10.1111/dmcn.15125. Online ahead of print. ABSTRACT AIM: To correlate clinical, radiological, and biochemical features with genetic findings in children with bilateral basal ganglia lesions of unknown aetiology, and propose a diagnostic algorithm for early recognition. METHOD:…

Continue Reading Genetic diagnosis of basal ganglia disease in childhood

Exact Sciences hiring Director, Bioinformatics in San Diego Metropolitan Area

Summary Of Major ResponsibilitiesThe Director, Bioinformatics is self-driven, working on multiple projects that are extremely complex in scope. As a thought leader, the Director, Bioinformatics brings their knowledge and expertise to bear in planning, design, and execution to ensure successful and timely completion of large or complex projects. The Director,…

Continue Reading Exact Sciences hiring Director, Bioinformatics in San Diego Metropolitan Area

Bioinformation Analysis Reveals IFIT1 as Potential Biomarkers in Centr

Introduction Tuberculosis (TB) is considered to be one of the top ten causes of death in the world, about a quarter of the world’s population is infected with M. tuberculosis.1 The World Health Organization (WHO) divides tuberculosis into pulmonary tuberculosis (PTB) and extra-pulmonary tuberculosis (EPTB). Although breakthroughs have been made…

Continue Reading Bioinformation Analysis Reveals IFIT1 as Potential Biomarkers in Centr

Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases

doi.org/10.1038/gim.2017.56Get rights and content Abstract Purpose Invasive diagnostic prenatal testing can provide the most comprehensive information about the genetic status of a fetus. Noninvasive prenatal screening methods, especially when using cell-free DNA (cfDNA), are often limited to reporting only on trisomies 21, 18, and 13 and sex chromosome aneuploidies. This…

Continue Reading Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases

Toll-like receptor 2/4 in Chinese patients with sepsis

Introduction Sepsis is a life-threatening organ dysfunction that results from an exaggerated host immune response to disseminate infection.1 Despite improvements in treatment strategies, sepsis remains a leading cause of death in critically ill patients worldwide.2 Low platelet number, known as thrombocytopenia, is common in infectious diseases (also sometimes referred to…

Continue Reading Toll-like receptor 2/4 in Chinese patients with sepsis

Sr. Manager of Manufacturing – Resumetojobs.com

NuProbe USA is seeking an experienced Sr. Manager, In-Vitro Diagnostics Operations who will be responsible for all aspects of manufacturing, including design transfer of newly developed products from research & development. The successful candidate will control production planning, scheduling and forecasting. The candidate will lead continuous improvements in manufacturing as…

Continue Reading Sr. Manager of Manufacturing – Resumetojobs.com

UniProtKB/SwissProt variant VAR_083726

Sequence information Variant position:  468 The position of the amino-acid change on the UniProtKB canonical protein sequence. Protein sequence length:  805 The length of the canonical sequence. Location on the sequence:   GTLPFTYMLEKWRWMVFKGE  I PKDQWMKKWWEMKREIVGVV The residue change on the sequence. Unless the variant is located at the beginning or at the end of…

Continue Reading UniProtKB/SwissProt variant VAR_083726

Microbial identification of bovine milk isolates compared between conventional culture, MALDITOF and 16S rRNA

Microbial identification of bovine milk isolates compared between conventional culture, MALDITOF and 16S rRNA 21st International Conference on Food Technology & Processing October 04-06, 2018 | London, UK David J Wilson, John R Middleton, Pamela R F Adkins and Gregory M Goodell Utah State University, USAUniversity of Missouri, USAThe Dairy…

Continue Reading Microbial identification of bovine milk isolates compared between conventional culture, MALDITOF and 16S rRNA

UniProtKB/SwissProt variant VAR_084538

Sequence information Variant position:  28 The position of the amino-acid change on the UniProtKB canonical protein sequence. Protein sequence length:  492 The length of the canonical sequence. Location on the sequence:   PPAIGPYYENHGYQPENPYP  A QPTVVPTVYEVHPAQYYPSP The residue change on the sequence. Unless the variant is located at the beginning or at the end of…

Continue Reading UniProtKB/SwissProt variant VAR_084538

La Jolla Institute for Immunology hiring Bioinformatics Postdoc – Systems Immunology of Infectious Diseases in San Diego, California, United States

The Peters Lab at the La Jolla Institute for Immunology (LJI) is looking for a bioinformatics postdoc to join our efforts in profiling immune system responses to a variety of infectious agents, such as M. tuberculosis and B. Pertussis, as well as various cancers. Qualified applicants will have the opportunity…

Continue Reading La Jolla Institute for Immunology hiring Bioinformatics Postdoc – Systems Immunology of Infectious Diseases in San Diego, California, United States

Efficient target cleavage by Type V Cas12a effectors programmed with split CRISPR RNA

doi: 10.1093/nar/gkab1227. Online ahead of print. Regina Shebanova  1 , Natalia Nikitchina  1   2 , Nikita Shebanov  1 , Vladimir Mekler  3 , Konstantin Kuznedelov  3 , Egor Ulashchik  4 , Ruslan Vasilev  5   6 , Olga Sharko  4 , Vadim Shmanai  4 , Ivan Tarassov  2 , Konstantin Severinov  1   3   7 , Nina Entelis  2…

Continue Reading Efficient target cleavage by Type V Cas12a effectors programmed with split CRISPR RNA

Characterization of Blood- Based Molecular Profiling in Pancreatic Adenocarcinoma

Introduction Most cases of pancreatic adenocarcinoma (PDAC) are diagnosed in the metastatic or locally advanced stage. It is the fourth leading cause of cancer death in the United States,1,2 with a 5-year overall survival (OS) around 10% in this country2 despite years of research and therapeutic development. For those patients…

Continue Reading Characterization of Blood- Based Molecular Profiling in Pancreatic Adenocarcinoma

Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia

1. Marder, S. R. & Cannon, T. D. Schizophrenia. N. Engl. J. Med. 381, 1753–1761. doi.org/10.1056/NEJMra1808803 (2019). Article  PubMed  CAS  Google Scholar  2. Keshavan, M. S. et al. Neuroimaging in Schizophrenia. Neuroimaging Clin. N. Am. 30, 73–83. doi.org/10.1016/j.nic.2019.09.007 (2020). Article  PubMed  Google Scholar  3. McCutcheon, R. A., Reis Marques, T….

Continue Reading Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia

A year of ToBRFV

Although 2021 was the year of viruses for the entire world population, it was even more so for growers, who were confronted with the infamous Tomato Brown Rugose Fruit Virus (ToBRFV). It has been quite a ride – which is, unfortunately, not over just yet. In order to give you…

Continue Reading A year of ToBRFV

CSIRO Postdoctoral Fellowship in Pathogen Genomics and Bioinformatics

CSIRO Postdoctoral Fellowship in Pathogen Genomics and Bioinformatics – Job posted on PostdocJobs.com CONNECT WITH US :    CSIRO Postdoctoral Fellowship in Pathogen Genomics and Bioinformatics Job Number: Date Posted: Dec 23, 2021 Application Deadline: Open Until Filled Job Description Acknowledgment of Country   CSIRO acknowledges the Traditional Owners of the…

Continue Reading CSIRO Postdoctoral Fellowship in Pathogen Genomics and Bioinformatics

Clinical Bioinformatics Analyst (m/w/d) – Foundation Medicine GmbH – Biology & Life Sciences

Clinical Bioinformatics Analyst (m/w/d) PENZBERG, GERMANY Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease. As a molecular information company, we are focused on fundamentally changing the way in which patients…

Continue Reading Clinical Bioinformatics Analyst (m/w/d) – Foundation Medicine GmbH – Biology & Life Sciences

Principal Scientist, Disease Strategy (Translational bioinformatics) on beHired.in

At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We…

Continue Reading Principal Scientist, Disease Strategy (Translational bioinformatics) on beHired.in

Microarray analysis and functional prediction of differentially expressed circular RNAs in acquired middle ear cholesteatoma | BioMedical Engineering OnLine

1. Castle JT. Cholesteatoma pearls: practical points and update. Head Neck Pathol. 2018;12(3):419–29. Article  Google Scholar  2. Xie S, Wang X, Ren J, Liu W. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma. Eur Arch Otorhinolaryngol. 2017;274(5):2071–8. Article  Google Scholar  3. Bhutta MF, Williamson IG,…

Continue Reading Microarray analysis and functional prediction of differentially expressed circular RNAs in acquired middle ear cholesteatoma | BioMedical Engineering OnLine

10q26 FGFR2 Break Apart FISH Probe Kit

1 0q26 FGFR2 Break Apart FISH Probe Kit For Research Use Only Not for Use in Diagnostic Procedures 0q26 FGFR2 Break Apart FISH Probe Kit 09N /R2 Key to Symbols Used 09N /R2 Reference Number Lot Number Global Trade Item Number Centromere D0S294 0q26. Region FGFR2 5 ATE SHGC-529 Telomere…

Continue Reading 10q26 FGFR2 Break Apart FISH Probe Kit

CASP5 and CR1 as potential biomarkers for Kawasaki disease: an Integrated Bioinformatics-Experimental Study

This article was originally published here BMC Pediatr. 2021 Dec 11;21(1):566. doi: 10.1186/s12887-021-03003-5. ABSTRACT BACKGROUND: Kawasaki disease (KD) is a pediatric inflammatory disorder causes coronary artery complications. The disease overlapping manifestations with a set of symptomatically like diseases such as bacterial and viral infections, juvenile idiopathic arthritis, Henoch-Schönlein purpura, infection…

Continue Reading CASP5 and CR1 as potential biomarkers for Kawasaki disease: an Integrated Bioinformatics-Experimental Study

Roche launches AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine

Next-generation sequencing (NGS) can better understand the genetic mechanisms associated with specific diseases and help promote personalise health care Preparing DNA for sequencing library is complicated and prone to human error, which can interfere with accurate sequencing results The new AVENIO Edge system is a fully automated solution for sample…

Continue Reading Roche launches AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine

Roche launches the AVENIO Edge System to simplify and

Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO Edge System is a fully-automated solution for the…

Continue Reading Roche launches the AVENIO Edge System to simplify and

Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability

doi: 10.3389/fmolb.2021.737821. eCollection 2021. Affiliations Expand Affiliations 1 Laboratory For Clinical and Genomic Bioinformatics, I.M. Sechenov First Moscow State Medical University, Moscow, Russia. 2 Moscow Institute of Physics and Technology, Dolgoprudny, Russia. 3 OmicsWay Corp., Walnut, CA, United States. 4 Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia. 5…

Continue Reading Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability

Intern, Bioinformatics Associate job in San Diego at Hologic

As a leading global healthcare and diagnostics company, we strive to make advances toward greater certainty for our customers by providing them with cutting-edge technology that makes a real difference. We move to narrow the gap between doubt and confidence and work to achieve both incremental and transformational progress to…

Continue Reading Intern, Bioinformatics Associate job in San Diego at Hologic

Role of GPs in changing landscape of fertility treatment

PRIMARY care has for years been the cornerstone of the Australian health care system and GPs represent an integral part of it. As they are frequently responsible for the first, and sometimes only, contact of individuals with the health care system, they can profoundly affect a patient’s experience, expectations and…

Continue Reading Role of GPs in changing landscape of fertility treatment

Bioinformatics Software Developer | IT Job Board

Opportunity to join the computational team of a exciting biotech. Your new company I am currently working alongside an Oxford based biotech that focuses on clinical research and diagnostic solutions. Founded by a team from the University of Oxford, they have aims to progress the future of genetic-based medicine and…

Continue Reading Bioinformatics Software Developer | IT Job Board

A 20-minute Molecular Diagnosis Test Can Detect the Omicron Variant: Report

A 20-minute Molecular Diagnosis Test Can Detect the Omicron Variant: Report On the 10th, POSTECH announced that a research group led by Professor Lee Jung-wook of the Department of Chemical Engineering had developed molecular diagnostic technology that can detect the Omicron variant in 20-30 minutes and will publish the results…

Continue Reading A 20-minute Molecular Diagnosis Test Can Detect the Omicron Variant: Report

Pharmacogenomic Testing Improves Psychiatric Drug Selections for Treatment-Intolerant or Treatment-Resistant Patients

Evidence-Based Pharmacogenomic Testing Drug efficacy test results inform alternative medication selections when first-line treatment is ineffective with no guidelines for drug substitutions SAN FRANCISCO, CALIFORNIA, UNITED STATES, December 12, 2021 /EINPresswire.com/ — U.S. and Hong Kong-based Rainbow Genomics launches the Rainbow Psycho-Pharmacogenomic(TM) Testing Services enabling physicians to improve outcomes of…

Continue Reading Pharmacogenomic Testing Improves Psychiatric Drug Selections for Treatment-Intolerant or Treatment-Resistant Patients

Molecular Diagnosis Test Can Detect Omicron Variant In 20 Minutes: Report

Korean researchers have developed molecular diagnostics technology that can detect Omicron Seoul: Korean researchers have developed molecular diagnostics technology that can detect Omicron variants. The technology development has been currently completed, and it is expected to take time for commercialization. POSTECH announced on the 10th that a research team led…

Continue Reading Molecular Diagnosis Test Can Detect Omicron Variant In 20 Minutes: Report

Natera launches Prospera with quantification to improve kidney graft rejection testing

Natera has announced the launch of Prospera with quantification, the only cell-free DNA (cfDNA) test for kidney rejection that provides three values—the quantity of donor-derived cfDNA (dd-cfDNA), fraction of dd-cfDNA, and total cfDNA—on every report. Combining these three metrics has been shown to improve sensitivity when evaluating transplant rejection, compared…

Continue Reading Natera launches Prospera with quantification to improve kidney graft rejection testing

Sr Scientist – IVD Development – Houston

NuProbe USA Inc . is looking for a Staff/Senior Scientist to lead the IVD project development program at NuProbe to support both research and in vitro diagnostic (IVD) assays for use in medical research, clinical trials, regulatory submissions, and clinical diagnostic use.  NuProbe USA is a rapidly growing company and…

Continue Reading Sr Scientist – IVD Development – Houston

bioinformatics vacancy

On the one hand, I really liked the diversity of the bioinformatics program, and, with a degree in bioinformatics, there are many possible career paths. Updated on 2 December 2021. Exact wages will depend on experience and the industry an individual works in. Working experience with structural antigen analyses and…

Continue Reading bioinformatics vacancy

Three More Biopharma Expansions to Round Out the Week

Today, three biotech companies, Innocoll Biotherapeutics, Genapsys, and Adicet Bio, announced relocation and expansion plans. Avison Young, a global commercial real estate company, announced that Innocoll Biotherapeutics opened a new office in Princeton, N.J. Innocoll is a biotherapeutics pharmaceutical company focused on developing and commercializing technologies to answer unmet health-care needs….

Continue Reading Three More Biopharma Expansions to Round Out the Week

Metagenomics for epidemiological surveillance in ONE HEALTH

Next-Generation Sequencing (NGS) technology has led to a new era of studying microorganisms. Using this tool, our knowledge and understanding of microbiology has expanded at a rapid pace compared to traditional methods that rely on cell culture, microscopy, serology, and polymerase chain reaction (PCR). At the community level, microorganisms…

Continue Reading Metagenomics for epidemiological surveillance in ONE HEALTH

Genome Bioinformatics Analyst – Pittsburgh

**Description** UPMC Presbyterian is hiring a Genome Bioinformatics Analyst to join the Molecular and Genomic Pathology Laboratory (MGP) team! This role will work a daylight schedule Monday through Friday. No weekends or holidays are required! The Molecular and Genomic Pathology Laboratory (MGP) is a dynamic state-of-the-art clinical laboratory that prides…

Continue Reading Genome Bioinformatics Analyst – Pittsburgh

The Evolving Treatment Landscape of Cholangiocarcinoma

Recent genomic profiling studies revealed that approximately 40% of patients with biliary tract cancers harbor actionable genomic mutations. The advances in the understanding and characterization of biliary tract cancers (BTCs), particularly intrahepatic cholangiocarcinoma (iCCA), and genomic profiling over the past decade have led to a rapid expansion of available treatment…

Continue Reading The Evolving Treatment Landscape of Cholangiocarcinoma

Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma

1. Metser, U., Hussey, D. & Murphy, G. Impact of (18)F-FDG PET/CT on the staging and management of follicular lymphoma. Br. J. Radiol. 87, 20140360 (2014). CAS  Article  Google Scholar  2. Freedman, A. & Jacobsen, E. Follicular lymphoma: 2020 update on diagnosis and management. Am. J. Hematol. 95, 316–327 (2020)….

Continue Reading Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma

Clockworks Analytics Expands Open API With Release of New Developer Portal

Raw Building Data—API Call Example The API Portal provides access to building and equipment information including raw asset data, HVAC faults, and calculated KPIs. Building teams are leveraging these powerful insights to inform workflow management, capital planning, risk assessment, maintenance prioritization, and resource planning. BOSTON (PRWEB) December 09, 2021 …

Continue Reading Clockworks Analytics Expands Open API With Release of New Developer Portal

Prognosis Biomarkers via WGCNA in HCC

Introduction According to the cancer statistics reported in 2020, hepatocellular carcinoma (HCC) is the main type of Primary Carcinoma of the Liver and the second leading causes of cancer-related death globally, with a five-year survival rate < 20%.1 Currently, surgical resection, a standard therapy for HCC, contributes to the prognosis…

Continue Reading Prognosis Biomarkers via WGCNA in HCC

Opening the book: How genome sequencing aids newborn screening

Ian Bolland caught up with Chris Hughes, managing director UK & Ireland of PerkinElmer, to discuss how its genome sequencing technology is used in newborn babies.  Many parents will be familiar with the heel prick test following a child’s birth and there is a good chance that PerkinElmer’s technology has been behind…

Continue Reading Opening the book: How genome sequencing aids newborn screening

Researchers develop diagnostic technology to detect the Omicron variant in 20 minutes

[Gettyimages Bank] SEOUL — South Korean researchers have developed a diagnostic technology that can detect the Omicron variant in 20 minutes. Researchers were able to acquire results in several days, opening the way for health officials to respond quickly even if a new variant occurs. Diagnostic kits can be easily made…

Continue Reading Researchers develop diagnostic technology to detect the Omicron variant in 20 minutes

Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test for Investigational Lymphoma Treatment

NEW YORK – Qiagen and Denovo Biopharma said on Thursday that they are collaborating to develop a blood-based companion diagnostic test to identify patients expressing a genomic biomarker who are likely to respond to Denovo’s investigational DB102 treatment for diffuse large B-cell lymphoma. Under the agreement, Qiagen will develop an…

Continue Reading Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test for Investigational Lymphoma Treatment

Qiagen (QGEN) Collaborates with Denovo to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. QIAGEN (NYSE: QGEN) and Denovo Biopharma LLC today announced a collaboration to develop a blood-based companion diagnostic (CDx) test to identify patients expressing Denovo Genomic Marker 1 (DGM1TM) who…

Continue Reading Qiagen (QGEN) Collaborates with Denovo to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL

Denovo Biopharma and QIAGEN partner to develop companion diagnostic test for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

– QIAGEN’s blood-based test will help to identify patients with Diffuse Large B-Cell Lymphoma (DLBCL) likely to respond to Denovo’s new investigational cancer treatment DB102 – The partners seek FDA premarket approval (PMA) of the companion diagnostic test in tandem with the new drug application (NDA) approval. SAN DIEGO and…

Continue Reading Denovo Biopharma and QIAGEN partner to develop companion diagnostic test for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

Qiagen And Denovo Biopharma Partner To Develop Companion Diagnostic Test For Treatment Of Diffuse Large B-Cell Lymphoma

Qiagen And Denovo Biopharma Partner To Develop Companion Diagnostic Test For Treatment Of Diffuse Large B-Cell Lymphoma Published: 12/09/2021 14:36 GMT Qiagen NV (QGEN) – Denovo Biopharma and Qiagen Partner to Develop Companion Diagnostic Test for Treatment of Diffuse Large B-cell Lymphoma (dlbcl).Partners Seek FDA Premarket Approval (pma) of Companion…

Continue Reading Qiagen And Denovo Biopharma Partner To Develop Companion Diagnostic Test For Treatment Of Diffuse Large B-Cell Lymphoma

UniProtKB/SwissProt variant VAR_084474

Sequence information Variant position:  205 The position of the amino-acid change on the UniProtKB canonical protein sequence. Protein sequence length:  496 The length of the canonical sequence. Location on the sequence:   ERSLDTLLEAVESRGGVPGG  C VLVPRADLRLGGQPAPPQLL The residue change on the sequence. Unless the variant is located at the beginning or at the end of…

Continue Reading UniProtKB/SwissProt variant VAR_084474

UniProtKB/SwissProt variant VAR_082259

Sequence information Variant position:  4075 The position of the amino-acid change on the UniProtKB canonical protein sequence. Protein sequence length:  4374 The length of the canonical sequence. Location on the sequence:   GQDAGGLLREWYMIISREMF  N PMYALFRTSPGDRVTYTINP The residue change on the sequence. Unless the variant is located at the beginning or at the end of…

Continue Reading UniProtKB/SwissProt variant VAR_082259

Reliability of Cell-Free DNA (cfDNA) Next Generation Sequencing in Predicting Chromosomal Structural Abnormalities and Cytogenetic-Risk Stratification of Patients with Myeloid Neoplasms

Oral and Poster Abstracts 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III Translational Research Maher Albitar, MD1*, Andrew Ip, MD, MSc2, Andre H. Goy, MD3*, Jeffrey Justin Estella, BS, MS1*, Ivan De Dios, BS1*,…

Continue Reading Reliability of Cell-Free DNA (cfDNA) Next Generation Sequencing in Predicting Chromosomal Structural Abnormalities and Cytogenetic-Risk Stratification of Patients with Myeloid Neoplasms

Mark Emmert said the toughest job in America is university president. Here are some harder jobs.

NCAA president Mark Emmert believes that being a university president is a very, very difficult. How tough does he think it is? Tougher than literally any other job. NCAA president Mark Emmert: “Being a university president is the hardest job in America” — Brett McMurphy (@Brett_McMurphy) December 8, 2021 I’ll…

Continue Reading Mark Emmert said the toughest job in America is university president. Here are some harder jobs.

Ethnic Diversity of DPD activity and the DPYD Gene

Plain Language Summary Fluoropyrimidine (FP; 5-FU, capecitabine) is a common chemotherapy used to treat many different cancers, including cancer of the colon and rectum, upper digestive tract, breast and head and neck. Cancer patients who receive FP chemotherapy are at risk of developing severe side effects from their treatment. A…

Continue Reading Ethnic Diversity of DPD activity and the DPYD Gene

Circulating Exosomal MicroRNAs as Diagnostic and Prognostic Biomarkers in Patients with Diffuse Large B-Cell Lymphoma

Background: Exosomal microRNAs (miRNAs) are potential biomarkers for a variety of tumors but have not yet been studied in diffuse large B-cell lymphoma (DLBCL). Here, we investigated the use of exosomal miRNAs in DLBCL diagnosis and prognosis. Methods: A total of 256 individuals, including 133 DLBCL patients, 94 healthy controls…

Continue Reading Circulating Exosomal MicroRNAs as Diagnostic and Prognostic Biomarkers in Patients with Diffuse Large B-Cell Lymphoma

Qiagen, Denovo Biopharma Partner To Develop Companion Diagnostic Test

Published: 12/09/2021 06:38 GMT Qiagen NV (QGEN) – Qiagen and Denovo Biopharma Partner to Develop Companion Diagnostic Test for Treatment of Diffuse Large B-cell Lymphoma (dlbcl).Qiagen’s Blood-based Test Will Help to Identify Patients With Diffuse Large B-cell Lymphoma (dlbcl) Likely to Respond to Denovo’s New Investigational Cancer Treatment Db102tm.Partners Seek…

Continue Reading Qiagen, Denovo Biopharma Partner To Develop Companion Diagnostic Test

Illumina Supports Norway’s Pioneering Precision Medicine Study

SAN DIEGO, Dec. 9, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ:ILMN), today announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing. The study will also evaluate the cost-effectiveness of implementing blood-based CGP in…

Continue Reading Illumina Supports Norway’s Pioneering Precision Medicine Study

QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

QIAGEN’s blood-based test will help to identify patients with Diffuse Large B-Cell Lymphoma (DLBCL) likely to respond to Denovo’s new investigational cancer treatment DB102TM The partners seek FDA premarket approval (PMA) of the companion diagnostic test in tandem with the new drug application (NDA) approval. New master collaboration agreement adds…

Continue Reading QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

Postdoctoral Fellow job with Cleveland Clinic – Genomic Medicine Institute

We are seeking multiple Experimental and Bioinformatics research positions (including Postdoctoral Research Fellows and Research Associate) to join the Alzheimer’s Network Medicine and Artificial Intelligence (AI) research group (www.lerner.ccf.org/gmi/cheng/) led by Dr. Feixiong Cheng at the Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute, and Department of Molecular Medicine at…

Continue Reading Postdoctoral Fellow job with Cleveland Clinic – Genomic Medicine Institute

Qiagen, Denovo To Develop Companion Diagnostic Test For Diffuse Large B-Cell Lymphoma Treatment

(RTTNews) – Qiagen (QGEN) and Denovo Biopharma said that they have collaborated to develop a blood-based companion diagnostic test to identify patients expressing Denovo Genomic Marker 1 who are likely to respond to Denovo’s investigational cancer drug DB102 for treatment of diffuse large B-cell lymphoma or DLBCL, one of the…

Continue Reading Qiagen, Denovo To Develop Companion Diagnostic Test For Diffuse Large B-Cell Lymphoma Treatment

Next Generation Sequencing Industry to Cross $34.8 Billion by 2027

DUBLIN, Dec. 8, 2021 /PRNewswire/ — The “Next Generation Sequencing Market, Global Forecast, Impact of COVID-19, Industry Trends, Growth, Opportunity By Types of Test, Company Analysis” report has been added to ResearchAndMarkets.com‘s offering. According to the report, the Global Next Generation Sequencing Market will reach US$ 34.8 Billion by 2027….

Continue Reading Next Generation Sequencing Industry to Cross $34.8 Billion by 2027

Bioscience company announces Westminster expansion | Business

Genapsys, a Silicon Valley-based bioscience company, will expand into Westminster and plans to hire up to 250 employees for its new location, officials said Wednesday. Genapsys develops technology that it says will pave the way for universal access to genomic information and make more advanced DNA studies easier for both…

Continue Reading Bioscience company announces Westminster expansion | Business

the spacer of sgrna will hybridize with this sequence of dna from the fragment shown below?

James Guys, does anyone know the answer? get the spacer of sgrna will hybridize with this sequence of dna from the fragment shown below? from EN Bilgi. Solved The spacer of sgRNA will hybridize with this sequence Answer to Solved The spacer of sgRNA will hybridize with this sequence Do…

Continue Reading the spacer of sgrna will hybridize with this sequence of dna from the fragment shown below?

Post Doctoral Research Associate Bioinformatics job with Beth Israel Deaconess Medical Center/Harvard Medical School

The Hide Lab at Harvard Medical School and BIDMC seeks a bioinformatics/computational biology postdoctoral fellow for training. We focus on target discovery, and diagnostic and therapeutic applications for Alzheimer’s Disease. The position is under the direction of Dr. Winston Hide (Systems RNA medicine) and is available immediately. For a list of publications…

Continue Reading Post Doctoral Research Associate Bioinformatics job with Beth Israel Deaconess Medical Center/Harvard Medical School

The number of genotype-phenotype associations validated in male infertility continues to grow

A new systematic review of the validated monogenic causes of male infertility strengthens the evidence base for emerging gene-disease relationships; the review hopes to encourage more routine genetic testing in clinics and identify gaps in our knowledge of male infertility genetics. In less than two years, the number of genes…

Continue Reading The number of genotype-phenotype associations validated in male infertility continues to grow

rRNA Analysis Based on Long-Read High-Throughput Sequencing Reveals a More Accurate Diagnostic for the Bacterial Infection of Ascites

. 2021 Nov 17;2021:6287280. doi: 10.1155/2021/6287280. eCollection 2021. Affiliations Expand Affiliations 1 Department of Infectious Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China. 2 Institute of Applied Genomics, Fuzhou University, Fuzhou 350108, China. Item in Clipboard Xiaoling Yu et al. Biomed Res Int. 2021. Show details Display options…

Continue Reading rRNA Analysis Based on Long-Read High-Throughput Sequencing Reveals a More Accurate Diagnostic for the Bacterial Infection of Ascites

Roche hiring Principal Bioinformatics Scientist in Pleasanton, California, United States

Impact Healthcare Roche is dedicated to advancing personalized healthcare by creating diagnostics and treatments tailored to individual genetic and disease profiles. As part of this mission, Roche Sequencing Solutions is unifying next-generation sequencing with the goal of making it routine sample in – result out. Make a Big Difference Cancer…

Continue Reading Roche hiring Principal Bioinformatics Scientist in Pleasanton, California, United States

Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes

NEW YORK – At the European Society for Medical Oncology Congress this week, precision oncology assay developer Lucence presented data that demonstrated its amplicon-based LiquidHallmark assay could be used to personalize care for people with advanced urothelial carcinoma. LiquidHallmark is a laboratory-developed test based on the company’s AmpliMark next-generation sequencing platform…

Continue Reading Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes

European antitrust regulator delivers ultimatum to Illumina over $8B Grail deal

The European Commission has delivered a list of objections to Illumina and Grail over their decision to proceed with their multibillion-dollar merger despite the regulators’ ongoing investigation. It also noted the measures watchdogs plan to take to cordon off the potential effects of the deal on the wider market. The commission…

Continue Reading European antitrust regulator delivers ultimatum to Illumina over $8B Grail deal

GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ — GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset the largest of its kind…

Continue Reading GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

GeneDx Announces the Sequencin – GuruFocus.com

GAITHERSBURG, Md., Sept. 21, 2021 GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ — GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset…

Continue Reading GeneDx Announces the Sequencin – GuruFocus.com

The Biostar Herald for Tuesday, September 21, 2021

The Biostar Herald publishes user submitted links of bioinformatics relevance. It aims to provide a summary of interesting and relevant information you may have missed. You too can submit links here. This edition of the Herald was brought to you by contribution from Istvan Albert, and was edited by Istvan…

Continue Reading The Biostar Herald for Tuesday, September 21, 2021

A Day in the Life of a Genetic Counselor in the Yale Genetics Department

Genetic counselors bridge the gap between the technical, scientific information of a genetic disease diagnosis or test result and the patient’s understanding of how their genetic information affects their health. With the widespread use of DNA sequencing in cancer and increasingly more conditions in the age of precision medicine, genetic…

Continue Reading A Day in the Life of a Genetic Counselor in the Yale Genetics Department

Illumina Ventures sets sights on European genomics startups with new $325M fund

Illumina Ventures, the independently managed venture capital firm bankrolled by the DNA sequencing giant, has closed its second investment fund, amassing $325 million in new commitments. ​The proceeds will be used to support genomics-focused, early-stage startups looking to build new clinical diagnostics and life science research tools as well as targeted…

Continue Reading Illumina Ventures sets sights on European genomics startups with new $325M fund

NovelStem Announces NewStem, Ltd. Was Selected by Illumina for its Global Illumina Accelerator

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. Boca Raton, Florida and Jerusalem, Israel–(Newsfile Corp. – September 20, 2021) – NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed…

Continue Reading NovelStem Announces NewStem, Ltd. Was Selected by Illumina for its Global Illumina Accelerator

Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer b

Introduction Prostate cancer (PCa) is one of the most common genitourinary system malignant tumor in men worldwide. In Asian countries, many patients with PCa are often diagnosed at an advanced stage maybe mostly because of a large population base with relatively backward economic development and imperfect cancer screening system of…

Continue Reading Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer b

Bioconductor – marray

    This package is for version 2.13 of Bioconductor; for the stable, up-to-date release version, see marray. Exploratory analysis for two-color spotted microarray data Bioconductor version: 2.13 Class definitions for two-color spotted microarray data. Fuctions for data input, diagnostic plots, normalization and quality checking. Author: Yee Hwa (Jean) Yang…

Continue Reading Bioconductor – marray

Why do non-smokers develop lung cancer? Healing practice

Why do people who have never smoked get lung cancer? In recent research, three subtypes of lung cancer were classified by non-smokers. (Photo: utah51/stock.adobe.com) Analysis: Lung cancer in non-smokers Even if smoking is the main risk factor for developing lung cancer, it is not uncommon for people who have never…

Continue Reading Why do non-smokers develop lung cancer? Healing practice

Persistent Systems hiring Bioinformatics Data Scientist – South SFO, CA in Santa Clara, California, United States

About PersistentWe are a trusted Digital Engineering and Enterprise Modernization partner, combining deep technical expertise and industry experience to help our clients anticipate what’s next. Our offerings and proven solutions create unique competitive advantage for our clients by giving them the power to see beyond and rise above. We are…

Continue Reading Persistent Systems hiring Bioinformatics Data Scientist – South SFO, CA in Santa Clara, California, United States

Researchers identify 28 new foods associated with disease outbreaks

September 17, 2021 2 min read Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email…

Continue Reading Researchers identify 28 new foods associated with disease outbreaks

Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020

1. Dudas, G. et al. Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature 544, 309–315 (2017). ADS  CAS  Article  Google Scholar  2. Kafetzopoulou, L. E. et al. Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak. Science 363, 74–77 (2019). ADS  CAS  Article …

Continue Reading Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020

cancer detection kaggle

Most of us have credit cards, but there are still some people that do not. Skin lesion detection and classification is always observed as a difficult problem to solve. Got it. We then applied dropout again to further prevent overfitting. This problem is important as it will potentially save a…

Continue Reading cancer detection kaggle

WSU researchers discover one way elk become infected with devastating hoof disease | WSU Insider

WSU scientists are researching a rapidly spreading disease that causes elk to suffer deformed hooves, lameness and increasingly poor health that often can lead to death. (Photo from WSU Elk Hoof Disease Research project) PULLMAN, Wash — Washington State University’s Elk Hoof Disease Research team has discovered one way in…

Continue Reading WSU researchers discover one way elk become infected with devastating hoof disease | WSU Insider

Hartmann Young hiring Associate Director Bioinformatics – A.I. Genomics in United States

Associate Director of Bioinformatics – A.I. Genomics Hartmann Young are exclusively partnered with a pioneer within precision metagenomics headhunt for an Associate Director Bioinformatics. The company are working with excitin technology that provides hands-off, AI-powered automated improved pathogen detection, genomic profiling, and quantification of tens of thousands of pathogens from…

Continue Reading Hartmann Young hiring Associate Director Bioinformatics – A.I. Genomics in United States

Beyond Ventures’ first investment, Prenetics, becomes first Hong Kong unicorn to go public

HONG KONG, Sept. 16, 2021 /PRNewswire/ — Hong Kong-based venture capital firm Beyond Ventures is pleased to support today’s announcement by the firm’s first investee company, Prenetics, that Prenetics, a global leader in genomic and diagnostic testing is set to merge with Artisan Acquisition Corp. (Nasdaq: ARTAU, “Artisan”), to become…

Continue Reading Beyond Ventures’ first investment, Prenetics, becomes first Hong Kong unicorn to go public

Identification of Prognosis-Associated Biomarkers in Thyroid Carcinoma

Introduction Thyroid cancer (TC) is a common endocrine malignancy with a rapidly increasing incidence worldwide, and the estimated new cases and deaths are notably higher in women than in men.1 Papillary thyroid carcinoma (PTC) is identified as the most common pathological type of TC, and accounts for approximately 80–85% of…

Continue Reading Identification of Prognosis-Associated Biomarkers in Thyroid Carcinoma

Jennifer Doudna’s CRISPR startup Mammoth Biosciences goes unicorn

The gene-editing tool CRISPR is moving toward the market, promising better tests, disease cures — and maybe even a woolly mammoth. The big picture: CRISPR is already a historic scientific achievement, but we’re just now entering the moment when it will begin to impact patients and possibly the planet. Driving…

Continue Reading Jennifer Doudna’s CRISPR startup Mammoth Biosciences goes unicorn

The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform

Next-Generation Sequencing Utilizing Tumor Tissue and/or Blood The identification of actionable genomic alterations in tumors such as mCRC was once performed by Sanger DNA sequencing of tumor DNA that was extracted from fixed paraffin-embedded tumor tissue, but this has now been replaced by next-generation sequencing (NGS), which allows for larger-scale…

Continue Reading The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform

Classifiers for predicting coronary artery disease

Introduction Coronary artery disease (CAD) is a complex pathology associated with behavioral and environmental factors.1–3 CAD shows high prevalence and is associated with a high fatality rate among cardiovascular diseases. The main manifestations of CAD are stable or unstable angina pectoris and identifiable or unrecognized myocardial infarction.4 The main risk…

Continue Reading Classifiers for predicting coronary artery disease

Tinashe Mugabe Says He Is Against Compulsory DNA Testing At Birth

There Will Be Disaster: Tinashe Mugabe Says He Is Against Compulsory DNA Testing At Birth     Tinashe Mugabe, the host of the popular television show, The Closure DNA Show, has said that he is against compulsory DNA tests at birth. Mugabe, who is affectionately known as the DNA Man,…

Continue Reading Tinashe Mugabe Says He Is Against Compulsory DNA Testing At Birth

Could protein engineers have built the next billion pound pharma company?

Peptone is using science to build the world’s first protein engineering operating system, combining AI with computational molecular physics. Above, a 3D illustration of proteins. Photo: Getty Life comes at you fast. At one point Peptone, a computational biophysics company, had been rejected by more than 150 investors. Now, it…

Continue Reading Could protein engineers have built the next billion pound pharma company?